Article Versions Notes

Chen L, Zheng X, Li J, Zhou B, Tao M, Yang Y, Wang Y, Zhan H, Zhang G, Shi J, et al. Discovery of (E)-1,3-Diphenyl-2-Propen-1-One Derivatives as Potent and Orally Active NLRP3 Inflammasome Inhibitors for Colitis. Molecules. 2025; 30(16):3340. https://doi.org/10.3390/molecules30163340

Chen, Liuzeng, Xiaoyu Zheng, Jiahui Li, Bin Zhou, Min Tao, Yuetian Yang, Yi Wang, Hao Zhan, Guoping Zhang, Jingbo Shi, and et al. 2025. "Discovery of (E)-1,3-Diphenyl-2-Propen-1-One Derivatives as Potent and Orally Active NLRP3 Inflammasome Inhibitors for Colitis" Molecules 30, no. 16: 3340. https://doi.org/10.3390/molecules30163340

Chen, L., Zheng, X., Li, J., Zhou, B., Tao, M., Yang, Y., Wang, Y., Zhan, H., Zhang, G., Shi, J., Zhang, X., & Ruan, B. (2025). Discovery of (E)-1,3-Diphenyl-2-Propen-1-One Derivatives as Potent and Orally Active NLRP3 Inflammasome Inhibitors for Colitis. Molecules, 30(16), 3340. https://doi.org/10.3390/molecules30163340